Agnes Gasoirek
Agnes Gasoirek is a senior clinical pharmacology specialist at Novo Nordisk, where she has contributed to research on the experimental weight-loss medication amycretin, which has shown promising results in helping participants lose significant amounts of weight without plateauing.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Agnes Gasoirek, a senior clinical pharmacology specialist at Novo Nordisk, wrote in the phase 1 study findings.
6